Le Lézard
Classified in: Health, Business
Subject: VEN

Skin & Cancer Associates, LLP Partners With Susquehanna Private Capital, LLC


BALA CYNWYD, Pa., April 16, 2018 /PRNewswire/ -- Susquehanna Private Capital, LLC (SPC), a middle market private equity firm and member of the Susquehanna International Group of Companies (SIG), is pleased to announce its partnership with Skin & Cancer Associates, LLP (SCA), a dermatology group practice based in South Florida that is led by acclaimed dermatologists.

"We are thrilled to partner with SCA. The foundation for this partnership is our shared vision for executing a dermatologist-led strategy that prioritizes superb patient care," said Mark Miller, Director at SPC. "We are excited about the opportunities that lie ahead to advance the practice of dermatology as we seek to align with like-minded dermatologists throughout the country."

"SCA chose SPC as its partner because of its deep understanding of dermatology and its desire to sustain and build upon SCA's reputation for being a leader in clinical practice and practice management. With SPC's support, we expect to grow rapidly through new partnerships and to find innovative ways to positively impact the future of dermatology in the United States," said Reuven Porges, M.D., CEO of SCA.

"We believe SCA's dermatologists and management team are poised to create a national platform," said Leo Helmers, Co-Founder and Group Head of SPC. "We are honored to support this effort."

With support from Dr. Porges and a Board of Directors that includes representation from academic dermatology, SCA will continue to be led by its physicians and administrative personnel who have decades of experience supporting dermatology practices. SCA is actively pursuing new partnership opportunities.

About Skin and Cancer Associates
Founded in the early 70's and headquartered in the Fort Lauderdale, Florida metropolitan region, SCA is a partnership of over 25 dermatology practices. SCA provides care through over 40 Board-certified dermatologists, including prominent leaders. The Company's practices are supported by a scalable practice management infrastructure, which is led by David Wagener, MBA, CPA, and a CAPP accredited dermatopathology lab.

About Susquehanna Private Capital
SPC is an affiliate of Susquehanna International Group, LLP ("SIG"), one of the world's largest privately-held financial services firms. SPC makes majority and minority investments in domestic, middle market companies across a variety of industries, including: aerospace, defense & government, business services, consumer, food & beverage, healthcare, industrials, and technology, media & telecom. The firm is backed by a unique and patient capital base that gives management teams the freedom and flexibility to pursue business plans that maximize long-term value creation.

For additional information, please visit www.spcllc.com.

Media Contact:           
David Wagener: [email protected]
Skin & Cancer Associates
1111 Park Centre Drive, Suite 300, Miami Gardens, FL 33169
Phone: (305) 623-5595 

SOURCE Skin and Cancer Associates


These press releases may also interest you

at 20:12
BCACC is pleased to announce that its Deputy Registrar, Kathy Lauriente, has been honoured with the Distinguished Service Award from Thompson Rivers University. The award recognizes stellar contributions to the University, community, and the public...

at 19:29
Suffolk DBT is proud to announce the completion of their initial expansion to accommodate the growing need for DBT therapy...

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...

at 17:31
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...



News published on and distributed by: